Pricing

F2G

1 follower

‌

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

Industries

Biotechnology

Headquarters

Manchester, United Kingdom

Employees

51-200

Links

Org chart

Francesco Maria Lavino

CEO

Collapse

Ralf Schmid

CFO

John H. Rex

Chief Medical Officer

Mike Birch

COO

Tony Kennedy

Chief Scientific & Development Officer

Janelle R. Anderson

Chief Business Officer

Mark Baglin

Chief Commercial Officer

Ana Zaccaro

Vice President Regulatory Affairs

Mark Bresnik, MD

Executive Director, Clinical R&D

Board & advisors

Chairman

Director

Director

Director

Director

Director

Non Executive Director

Nanna Lüneborg

Non Executive Director

Teams

Medical Affairs and Clinical Operations

12 people · 0 jobs

Leadership Team

7 people · 0 jobs

Science and Research Team

7 people · 0 jobs

Offices

HQ
5 positions, 0 job posts
GS
JO
AW
+1

Similar companies

QuellTX

4 followers

Sutro Biopharma

3 followers

Active Motif

3 followers

FUJIFILM Diosynth Biotechnologies

16 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Phaidon Press

3 followers

Marshmallow

6 followers

London School of Economics and Political Science

7 followers

Eikon Therapeutics

3 followers

Kraken

6 followers

Explore companies